71 related articles for article (PubMed ID: 1393590)
21. Protease "Clipsin" activity and beta-amyloid precursor protein degradation by Alzheimer brain.
Stratmann GC; Webster MT; Bhogal G; Francis PT; Bowen DM
Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):241S. PubMed ID: 8224397
[No Abstract] [Full Text] [Related]
22. Expression and distribution of amyloid precursor protein-like protein-2 in Alzheimer's disease and in normal brain.
Crain BJ; Hu W; Sze CI; Slunt HH; Koo EH; Price DL; Thinakaran G; Sisodia SS
Am J Pathol; 1996 Oct; 149(4):1087-95. PubMed ID: 8863657
[TBL] [Abstract][Full Text] [Related]
23. Enhanced aggregation of beta-amyloid-containing peptides by extracellular matrix and their degradation by the 68 kDa serine protease prepared from human brain.
Matsumoto A; Enomoto T; Fujiwara Y; Baba H; Matsumoto R
Neurosci Lett; 1996 Dec; 220(3):159-62. PubMed ID: 8994217
[TBL] [Abstract][Full Text] [Related]
24. Age and damage induced changes in amyloid protein precursor immunohistochemistry in the rat brain.
Beeson JG; Shelton ER; Chan HW; Gage FH
J Comp Neurol; 1994 Apr; 342(1):69-77. PubMed ID: 8207128
[TBL] [Abstract][Full Text] [Related]
25. Cerebral amyloid β(42) deposits and microvascular pathology in ageing baboons.
Ndung'u M; Härtig W; Wegner F; Mwenda JM; Low RW; Akinyemi RO; Kalaria RN
Neuropathol Appl Neurobiol; 2012 Aug; 38(5):487-99. PubMed ID: 22126319
[TBL] [Abstract][Full Text] [Related]
26. A putative role for cathepsin K in degradation of AA and AL amyloidosis.
Röcken C; Stix B; Brömme D; Ansorge S; Roessner A; Bühling F
Am J Pathol; 2001 Mar; 158(3):1029-38. PubMed ID: 11238051
[TBL] [Abstract][Full Text] [Related]
27. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel serine protease-like molecule in human brain.
Meckelein B; Marshall DC; Conn KJ; Pietropaolo M; Van Nostrand W; Abraham CR
Brain Res Mol Brain Res; 1998 Apr; 55(2):181-97. PubMed ID: 9582421
[TBL] [Abstract][Full Text] [Related]
29. The Alzheimer's amyloid precursor protein is produced by type I astrocytes in primary cultures of rat neuroglia.
Berkenbosch F; Refolo LM; Friedrich VL; Casper D; Blum M; Robakis NK
J Neurosci Res; 1990 Mar; 25(3):431-40. PubMed ID: 2109094
[TBL] [Abstract][Full Text] [Related]
30. Amyloid deposition in APP23 mice is associated with the expression of cyclins in astrocytes but not in neurons.
Gärtner U; Brückner MK; Krug S; Schmetsdorf S; Staufenbiel M; Arendt T
Acta Neuropathol; 2003 Dec; 106(6):535-44. PubMed ID: 12923647
[TBL] [Abstract][Full Text] [Related]
31. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
[TBL] [Abstract][Full Text] [Related]
32. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease.
Zhang Z; Song M; Liu X; Su Kang S; Duong DM; Seyfried NT; Cao X; Cheng L; Sun YE; Ping Yu S; Jia J; Levey AI; Ye K
Nat Commun; 2015 Nov; 6():8762. PubMed ID: 26549211
[TBL] [Abstract][Full Text] [Related]
33. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
Mann DM; Iwatsubo T; Ihara Y; Cairns NJ; Lantos PL; Bogdanovic N; Lannfelt L; Winblad B; Maat-Schieman ML; Rossor MN
Am J Pathol; 1996 Apr; 148(4):1257-66. PubMed ID: 8644866
[TBL] [Abstract][Full Text] [Related]
34. A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease.
Small DH; Moir RD; Fuller SJ; Michaelson S; Bush AI; Li QX; Milward E; Hilbich C; Weidemann A; Beyreuther K
Biochemistry; 1991 Nov; 30(44):10795-9. PubMed ID: 1718425
[TBL] [Abstract][Full Text] [Related]
35. Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues.
Nakanishi H; Tominaga K; Amano T; Hirotsu I; Inoue T; Yamamoto K
Exp Neurol; 1994 Mar; 126(1):119-28. PubMed ID: 8157122
[TBL] [Abstract][Full Text] [Related]
36. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
[TBL] [Abstract][Full Text] [Related]
37. beta-Amyloid protein precursor in Microcebus murinus: genotyping and brain localization.
Silhol S; Calenda A; Jallageas V; Mestre-Frances N; Bellis M; Bons N
Neurobiol Dis; 1996; 3(3):169-82. PubMed ID: 8980017
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
[TBL] [Abstract][Full Text] [Related]
39. Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology.
Mohajeri MH; Saini KD; Nitsch RM
J Neural Transm (Vienna); 2004 Mar; 111(3):413-25. PubMed ID: 14991462
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoids facilitate astrocytic amyloid-β peptide deposition by increasing the expression of APP and BACE1 and decreasing the expression of amyloid-β-degrading proteases.
Wang Y; Li M; Tang J; Song M; Xu X; Xiong J; Li J; Bai Y
Endocrinology; 2011 Jul; 152(7):2704-15. PubMed ID: 21558319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
